Publication

Publications

Publications Fast Access

2024 | 2023 | 2022 | 2021 | 2020 |2019 | 2018 | 2017 | 2016  | 2015 | 2014 | 2012 | 2011 | Before 2010  | Patents

  2024

Book chapters

  1. Serap Sezen, Çiğdem Bilici, Atefeh Zarepour, Arezoo Khosravi, Ali Zarrabi, Ebrahim Mostafavi, (2024) Mechanical Properties of Multifunctional Hydrogels, In Multifunctional Hydrogels (Chapter 11), Taylor & Francis.
     

Original papers

  1. Zahra Assadi, Parsa Rezvanian, Zahra Gounani, Fatemeh Ejeian, Ali Zarrabi, Elahe Masaeli, (2024) Multilayered nanocomposite membrane orchestrating targeted dual release strategies for enhanced guided bone regeneration. Chemical Engineering Journal, 484, 149237. (TOP 5% Journal; I.F.= 15.1)
  2. Yasaman Esmaeili, Arezou Dabiri, Fariba Mashayekhi, Ilnaz Rahimmanesh, Elham Bidram, Saeed Karbasi, Mohammad Rafienia, Shaghayegh Haghjooy Javanmard, Yavuz Nuri Ertas, Ali Zarrabi, Laleh Shariati, (2024) Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer. Biomedicine & Pharmacotherapy, 173, 116465.
  3. Seyed Mohammad Reza Hosseini, Parisa Heydari, Mahtab Namnabat, Reyhaneh Nasr Azadani, Fateme Azimi Gharibdousti, Elmira Mousavi Rizi, Arezoo Khosravi, Atefeh Zarepour, Ali Zarrabi, (2024) Carboxymethyl cellulose/Sodium alginate Hydrogel with Anti-inflammatory capabilities for Accelerated Wound healing; In vitro and In vivo study. European Journal of Pharmacology, in press.
  4. Fatemeh Bagheri, Ahmad Saudi, Elham Bidram, Azadeh Asefnejad, Alireza Sanati, Ali Zarrabi, Mohammad Rafienia, (2024) Fabrication of 3D porous polyurethane-graphene oxide scaffolds by a sequential two-step processing for non-load bearing bone defects. Physica Scripta, 99, 045023.
     

Review papers

  1. Hossein Abolhassani, Alireza Eskandari, Anita Saremi Poor, Ali Zarrabi, Behnoosh Khodadadi, Sara Karimifard, Hamidreza Sahrayi, Mahsa Bourbour, Mohammad Tavakkoli Yaraki, (2024) Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models. Coordination Chemistry Reviews, 508, 215754. (TOP 1% Journal; I.F.= 20.6)
  2. Ehsan Nazarzadeh Zare, Danial Khorsandi, Atefeh Zarepour, Hulya Yilmaz, Tarun Agarwal, Sara Hooshmand, Reza Mohammadinejad, Fatma Ozdemir, Onur Sahin, Sevin Adiguzel, Haroon Khan, Ali Zarrabi, Esmaeel Sharifi, Arun Kumar, Ebrahim Mostafavi, Negar Hosseinzadeh Kouchehbaghi, Virgilio Mattoli, Feng Zhang, Vadim Jucaud, Alireza Hassani Najafabadi, Ali Khademhosseini, (2024) Biomedical applications of engineered heparin-based materials. Bioactive Materials, 31, 87. (TOP 1% Journal; I.F.= 18.9)
  3. Hazal Ezgi Gültekin, Gökçen Yaşayan, Ayça Bal-Öztürk, Ashkan Bigham, Abdolreza Arash Simchi, Atefeh Zarepour, Siavash Iravani, Ali Zarrabi, (2024) Advancements and applications of upconversion nanoparticles in wound dressings. Materials Horizons, 11, 363. (TOP 10% Journal; I.F.= 13.3)
  4. Ashkan Bigham, Negar Islami, Arezoo Khosravi, Atefeh Zarepour, Siavash Iravani, Ali Zarrabi, (2024) MOFs and MOF‐Based Composites as Next‐Generation Materials for Wound Healing and Dressings. Small, in press. (TOP 10% Journal; I.F.= 13.3)
  5. Arezoo Khosravi, Atefeh Zarepour, Siavash Iravani, Rajender S Varma, Ali Zarrabi, (2024) Sustainable synthesis: natural processes shaping the nanocircular economy. Environmental Science: Nano, 11, 688.
  6. Thomas Scattolin, Giovanni Tonon, Eleonora Botter, Viviana Claudia Canale, Mahdi Hasanzadeh, Denise Maria Cuscela, Annamaria Buschini, Atefeh Zarepour, Arezoo Khosravi, Marco Cordani, Flavio Rizzolio, Ali Zarrabi, (2024) Synergistic applications of cyclodextrin-based systems and metal–organic frameworks in transdermal drug delivery for skin cancer therapy. Journal of Materials Chemistry B, in press.

 

  2023

Editorials

  1. Ali Zarrabi, (2023) Could the Convergence of Science and Technology Guarantee Human Health in the Future? Bioengineering, 10, 589.
  2. Ali Zarrabi, Fabrizio Caldera, Francesco Trotta, (2023) Materials for Infectious Diseases. International Journal of Molecular Sciences, 24, 3295. 
     

Book chapters

  1. Ali Zarrabi, (2023) Biological applications of green bionanomaterials: diagnosis applications, In Synthesis of Bionanomaterials for Biomedical Applications (443-467), Elsevier.
     

Original papers

  1. Shaghayegh Saharkhiz, Atefeh Zarepour, Ali Zarrabi, (2023) A new theranostic pH-responsive niosome formulation for Doxorubicin delivery and bio-imaging against breast cancer. International Journal of Pharmaceutics, 637, 122845.
  2. Alireza Sanati, Yasaman Esmaeili, Mohammad Khavani, Azadeh Rahimi, Arezou Dabiri, Mohammad Rafienia, Nafise Arbab Jolfaie, Mohammad R. K. Mofrad, Shaghayegh Haghjooye Javanmard, Elham Bidram, Laleh Shariati, Ali Zarrabi, (2023) Smartphone-assisted lab-in-a-tube cytosensor using gold nanocluster-based aptasensor for detection of MUC1-overexpressed tumor cells. Analytica Chimica Acta, 1252, (TOP 10% Journal; I.F.= 6.91)
  3. Yasaman Esmaeili, Zahra Mohammadi, Mohammad khavani, Alireza Sanati, Laleh Shariati, Hooria Seyedhosseini Ghaheh, Elham Bidram, Ali Zarrabi, (2023) Fluorescence Anisotropy Cytosensing of Folate Receptor Positive Tumor Cells Using 3D polyurethane-GO-Foams modified with folic acid: Molecular Dynamics and In Vitro Studies. Microchimica Acta, 190, 44.
  4. Atefeh Zarepour, Abdurrahim Can Egil, Melike Cokol Cakmak, Monireh Esmaeili Rad, Yuksel Cetin, Seyma Aydinlik, Gozde Ozaydin Ince, Ali Zarrabi, (2023) Fabrication of dual drug loaded smart niosome-g-chitosan polymeric platform for lung cancer treatment, Polymers, 15, 298.
  5. Zahra Mohammadpour, Mahshid Kharaziha, Ali Zarrabi, (2023) 3D-Printing of Silk Nanofibrils Reinforced Alginate for Soft Tissue Engineering. Pharmaceutics, 15, 763.
  6. Niloofar Rafie, Mohammad Khodadadi, Mohammadreze Zamani, Atefeh Zarepour, Ali Zarrabi, (2023) Magnetic silica nanoparticles adorned with a metal-organic framework; a novel nanosorbent for elimination of aqueous Pb ions contaminant. Environmental Research, 226, 115694.
  7. Shaghayegh Saharkhiz, Atefeh Zarepour, Negar Nasri, Marco Cordani, Ali Zarrabi, (2023) A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy. European Journal of Pharmaceutical Sciences, 191, 106600.
  8. Sepideh Mirzaei, Mohammad Hossein Gholami, Hamid Asadzadeh Aghdaei, Mehrdad Hashemi, Kazem Parivar, Amin Karamian, Ali Zarrabi, Milad Ashrafizadeh, Jianlin Lu, (2023) Exosome-mediated miR-200a delivery into TGF-β-treated AGS cells abolished epithelial-mesenchymal transition with normalization of ZEB1, vimentin and Snail1 expression. Environmental Research, 231, 116115.
     

Review papers

  1. Atefeh Zarepour, Sepideh Ahmadi, Navid Rabiee, Ali Zarrabi, Siavash Iravani, (2023) Self-healing MXene- and Graphene-based Composites: Properties and Applications. Nano-Micro Letters, 15, 100. (TOP 5% Journal; I.F.= 23.65)
  2. Gökçen Yaşayan, Omid Nejati, Asli F Ceylan, Çimen Karasu, Pelin Kelicen Ugur, Ayça Bal-Öztürk, Atefeh Zarepour, Ali Zarrabi, Ebrahim Mostafavi, (2023) Tackling chronic wound healing using nanomaterials: advancements, challenges, and future perspectives. Applied Materials Today, 32, 101829.
  3. Ayça Bal-Öztürk, Ece Özcan-Bülbül, Hazal Ezgi Gültekin, Berivan Cecen, Ebru Demir, Atefeh Zarepour, Sibel Cetinel, Ali Zarrabi, (2023) Application of Convergent Science and Technology toward Ocular Disease Treatment. Pharmaceuticals, 16, 445.
  4. Parisa Dehghani, Monireh Esmaeili Rad, Atefeh Zarepour, Ponnurengam Malliappan Sivakumar, Ali Zarrabi, (2023) An insight into the polymeric nanoparticles applications in diabetes diagnosis and treatment. Mini-Reviews in Medicinal Chemistry, 23, 192.
  5. Berivan Cecen, Ecem Saygili, Iman Zare, Omid Nejati, Danial Khorsandi, Atefeh Zarepour, Emine Alarcin, Ali Zarrabi, Seda Nur Topkaya, Ozlem Yesil-Celiktas, Ebrahim Mostafavi, Ayça Bal-Öztürk, (2023) Biosensor Integrated Brain-on-a-Chip Platforms: Progress and Prospects in Clinical Translation. Biosensors and Bioelectronics, 225, 115100. (TOP 10% Journal; I.F.= 12.54)
  6. Vijay Sagar Madamsetty, Maryam Vazifehdoost, Samira Hossaini Alhashemi, Hesam Davoudi, Ali Zarrabi, Ali Dehshahri, Hojjat Samareh Fekri, Reza Mohammadinejad, Vijay Kumar Thakur, (2023) Next-Generation Hydrogels as Biomaterials for Biomedical Applications: Exploring the Role of Curcumin. ACS Omega, 8, 8960. (Featured on the journal cover)
  7. Afshin Taheriazam, Ghazaleh Gholamiyan Yousef Abad, Shima Hajimazdarany, Mohammad Hassan Imani, Setayesh Ziaolhagh, Mohammad Arad Zandieh, Seyedeh Delaram Bayanzadeh, Sepideh Mirzaei, Michael R Hamblin, Maliheh Entezari, Amir Reza Aref, Ali Zarrabi, Yavuz Nuri Ertas, Jun Ren, Romina Rajabi, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, Kiavash Hushmandi, (2023) Journal of Controlled Release, 354, 503. (TOP 10% Journal; I.F.= 11.46)
  8. Minmin Shao, Ashkan Bigham, Satar Yousefiasl, Cynthia KY Yiu, Yarabahally R Girish, Matineh Ghomi, Esmaeel Sharifi, Serap Sezen, Ehsan Nazarzadeh Zare, Ali Zarrabi, Navid Rabiee, Ana Cláudia Paiva‐Santos, Serena Del Turco, Baolin Guo, Xiangdong Wang, Virgilio Mattoli, Aimin Wu, (2023) Recapitulating Antioxidant and Antibacterial Compounds into a Package for Tissue Regeneration: Dual Function Materials with Synergistic Effect. Small, 19, 2207057. (TOP 10% Journal; I.F.= 15.15)
  9. Farinaz Hadinejad, Hamed Morad, Mohsen Jahanshahi, Ali Zarrabi, Hamidreza Pazoki-Toroudi, Ebrahim Mostafavi, (2023) A Novel Vision of Reinforcing Nanofibrous Masks with Metal Nanoparticles: Antiviral Mechanisms Investigation. Advanced Fiber Materials, in press. (TOP 6% Journal; I.F.= 12.95)
  10. Milad Ashrafizadeh, Ali Zarrabi, Ashkan Bigham, Afshin Taheriazam, Yalda Saghari, Sepideh Mirzaei, Mehrdad Hashemi, Kiavash Hushmandi, Hassan Karimi‐Maleh, Ehsan Nazarzadeh Zare, Esmaeel Sharifi, Yavuz Nuri Ertas, Navid Rabiee, Gautam Sethi, Mingzhi Shen, (2023) (Nano) platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy. Medicinal Research Reviews, in press. (TOP 3% Journal; I.F.= 12.38)
     

2022

Original papers

  1. Yasaman Esmaeili, Mohammad Khavani, Ashkan Bigham, Alireza Sanati, Elham Bidram, Laleh Shariati, Ali Zarrabi, Nafise Arbab Jolfaie, Mohammad Rafienia, (2022) Mesoporous silica@ chitosan@ gold nanoparticles as “on/off” optical biosensor and pH-sensitive theranostic platform against cancer. International Journal of Biological Macromolecules, 202, 241. (TOP 15% Journal)
  2. H Maleki-Ghaleh, MS Shakeri, Z Dargahi, M Kavanlouei, H Kaveh Garabagh, E Moradpur-Tari, A Yourdkhani, A Fallah, A Zarrabi, B Koc, MH Siadati, (2022) Characterization and optical properties of mechanochemically synthesized molybdenum-doped rutile nanoparticles and their electronic structure studies by density functional theory. Materials Today Chemistry, 24, 100820.
  3. Fatemeh Paknia, Hassan Mohabatkar, Meysam Ahmadi-Zeidabadi, Ali Zarrabi, (2022) The convergence of in silico approach and nanomedicine for efficient cancer treatment; in vitro investigations on curcumin loaded multifunctional graphene oxide nanocomposite structure. Journal of Drug Delivery Science and Technology, 71, 103302.
  4. Saba Taheri, Fatemeh Hosseinpour Motlagh, Sina Dehestanizad, Hossein Yahyaei, Amir Motallebzadeh, Ali Zarrabi, Abolfazl Golmohammadian Tehrani, Mohammadreza Khodabakhsh, Hesam Makki, (2022) The effect of surface chemistry on anti-soiling properties of transparent perfluoroalkyl and alkyl modified silica coatings. Surfaces and Interfaces, 30, 101824.
  5. Narjes Firouzkouhi, Abbas Amini, Chun Cheng, Ali Zarrabi, Bijan Davvaz, (2022) Intuitionistic fuzzy set of Γ -submodules and its application in modeling spread of viral diseases, mutated COVID-n, via flights. International Journal of Intelligent Systems, in press. (TOP 10% Journal)

Review papers

  1. Yasaman Esmaeili, Zahra Yarjanli, Fatemeh Pakniya, Elham Bidram, Marek J Los, Mehdi Eshraghi, Daniel J Klionsky, Saeid Ghavami, Ali Zarrabi, (2022) Targeting autophagy, oxidative stress, and ER stress for neurodegenerative diseases treatment. Journal of Controlled Release, 345, 147-175. (TOP 10% Journal)
  2. Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, John D Schneible, Iman Fatemi, Abdolsamad Shirvani, Ali Zarrabi, Fereshteh Azedi, Ali Dehshahri, Abbas Aghaei Afshar, Kian Aghaabbasi, Abbas Pardakhty, Reza Mohammadinejad, Prashant Kesharwani, (2022) Chitosan: A versatile bio-platform for breast cancer theranostics. Journal of Controlled Release, 341, 733. (TOP 10% Journal)
  3. Sepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, Farid Hshemi, Amirhossein Zabolian, Israel Canadas, Ali Zarrabi, Noushin Nabavi, Amir Reza Aref, Francesco Crea, Yuzhuo Wang, Milad Ashrafizadeh, Alan Prem Kumar, (2022) The long and short non-coding RNAs modulating EZH2 signaling in cancer. Journal of Hematology & Oncology, 15, 1-34. (TOP 5% Journal)
  4. Milad Ashrafizadeh, Hamidreza Saebfar, Mohammad Hossein Gholami, Kiavash Hushmandi, Amirhossein Zabolian, Pooria Bikarannejad, Mehrdad Hashemi, Salman Daneshi, Sepideh Mirzaei, Esmaeel Sharifi, Alan Prem Kumar, Haroon Khan, Hamid Heydari Sheikh Hossein, Massoud Vosough, Navid Rabiee, Vijay Thakur Kumar, Pooyan Makvandi, Yogendra Kumar Mishra, Franklin R Tay, Yuzhuo Wang, Ali Zarrabi, Gorka Orive, Ebrahim Mostafavi, (2022) Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: Stimuli-responsive carriers, co-delivery and suppressing resistance. Expert Opinion on Drug Delivery, in press.
  5. Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, Amirhossein Zabolian, Shima Mohammadi, Farima Fakhri, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Ali Zarrabi, Yavuz Nuri Ertas, Sepideh Mirzaei, Saeed Samarghandian, (2022) AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomedicine & Pharmacotherapy, 146, 112563. (TOP 10% Journal)
  6. Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, John D Schneible, Iman Fatemi, Abdolsamad Shirvani, Ali Zarrabi, Fereshteh Azedi, Ali Dehshahri, Abbas Aghaei Afshar, Kian Aghaabbasi, Abbas Pardakhty, Reza Mohammadinejad, Prashant Kesharwani, (2022) Chitosan: A versatile bio-platform for breast cancer theranostics. Journal of Controlled Release, 341, 733. (TOP 10% Journal)
  7. Esmaeel Sharifi, Ashkan Bigham, Satar Yousefiasl, Maria Trovato, Matineh Ghomi, Yasaman Esmaeili, Pouria Samadi, Ali Zarrabi, Milad Ashrafizadeh, Shokrollah Sharifi, Rossella Sartorius, Farnaz Dabbagh Moghaddam, Aziz Maleki, Hao Song, Tarun Agarwal, Tapas Kumar Maiti, Nasser Nikfarjam, Colin Burvill, Virgilio Mattoli, Maria Grazia Raucci, Kai Zheng, Aldo R Boccaccini, Luigi Ambrosio, Pooyan Makvandi, (2022) Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli‐Responsive, Toxicity, Immunogenicity, and Clinical Translation. Advanced Science, 9, 2102678. (Impact Factor: 16.8)
  8. Mahshid Deldar Abad Paskeh, Atefeh Mehrabi, Mohammad Hossein Gholami, Amirhossein Zabolian, Ehsan Ranjbar, Hossein Saleki, Adnan Ranjbar, Mehrdad Hashemi, Yavuz Nuri Ertas, Kiavash Hushmandi, Sepideh Mirzaei, Milad Ashrafizadeh, Ali Zarrabi, Saeed Samarghandian, (2022) EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects. Biomedicine & Pharmacotherapy, 146, 112532. (TOP 10% Journal)
  9. Sajad Najafi, Shing Cheng Tan, Pourya Raee, Yazdan Rahmati, Yahya Asemani, E Hui Clarissa Lee, Kiavash Hushmandi, Ali Zarrabi, Amir Reza Aref, Milad Ashrafizadeh, Alan Prem Kumar, Yavuz Nuri Ertas, Sepideh Ghani, Shahin Aghamiri, (2022) Gene regulation by antisense transcription: A focus on neurological and cancer diseases. Biomedicine & Pharmacotherapy, 145, 112265. (TOP 10% Journal)
  10. Atieh Jahangiri-Manesh, Marziyeh Mousazadeh, Shirinsadat Taji, Abbas Bahmani, Atefeh Zarepour, Ali Zarrabi, Esmaeel Sharifi, Mostafa Azimzadeh, (2022) Gold Nanorods for Drug and Gene Delivery: An Overview of Recent Advancements. Pharmaceutics, 14, 664. (TOP 10% Journal)
  11. Milad Ashrafizadeh, Alan Prem Kumar, Amir Reza Aref, Ali Zarrabi, Ebrahim Mostafavi, (2022) Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications. International Journal of Nanomedicine, 17, 1229—1253.
  12. Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, Ali Zarrabi, Michael R Hamblin, Maliheh Entezari, Mehrdad Hashemi, Amir Reza Aref, Kiavash Hushmandi, Alan Prem Kumar, Navid Rabiee, Milad Ashrafizadeh, Saeed Samarghandian, (2022) Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator? International Journal of Biological Macromolecules, 206, 435-452.
  13. Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Mohammad Hossein Gholami, Ali Zarrabi, Farid Hashemi, Kiavash Hushmandi, Mehrdad Hashemi, Noushin Nabavi, Francesco Crea, Jun Ren, Daniel J Klionsky, Alan Prem Kumar, Yuzhuo Wang, (2022) Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. Journal of Experimental & Clinical Cancer Research, 41, 1-37.
  14. Fatemeh Hajibabaie, Navid Abedpoor, Nazanin Assareh, Mohammad Amin Tabatabaiefar, Laleh Shariati, Ali Zarrabi, (2022) The Importance of SNPs at miRNA Binding Sites as Biomarkers of Gastric and Colorectal Cancers: A Systematic Review. Journal of Personalized Medicine, 12, 456.
  15. Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, Farid Hashemi, Amirhossein Zabolian, Fardin Hashemi, Pourya Raee, Shahin Aghamiri, Milad Ashrafizadeh, Amir Reza Aref, Michael R Hamblin, Kiavash Hushmandi, Ali Zarrabi, Gautam Sethi, (2022) Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytotherapy Research, 36, 189.
  16. Dario Presutti, Tarun Agarwal, Atefeh Zarepour, Nehar Celikkin, Sara Hooshmand, Chinmay Nayak, Matineh Ghomi, Ali Zarrabi, Marco Costantini, Birendra Behera, Tapas Kumar Maiti, (2022) Transition Metal Dichalcogenides (TMDC)-Based Nanozymes for Biosensing and Therapeutic Applications. Materials, 15, 337.
  17. Mahshid Deldar Abad Paskeh, Maliheh Entezari, Courtney Clark, Amirhossein Zabolian, Ehsan Ranjbar, Mahdi Vasheghani Farahani, Hossein Saleki, Seyed Omid Sharifzadeh, Fatemeh Bakhtiari Far, Milad Ashrafizadeh, Saeed Samarghandian, Haroon Khan, Saeid Ghavami, Ali Zarrabi, Marek J Łos, (2022) Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1868, 166326.
  18. Shahram Taeb, Milad Ashrafizadeh, Ali Zarrabi, Saeed Rezapoor, Ahmed Eleojo Musa, Bagher Farhood, Masoud Najafi, (2022) Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy. Current Cancer Drug Targets, 22.

 2021

Original papers

  1. Maleki-Ghaleh, H., Siadati, M.H., Fallah, A., Zarrabi, A., Afghah, F., Koc, B., Abdolahinia, E.D., Omidi, Y., Barar, J., Akbari-Fakhrabadi, A., Beygi-Khosrowshahi, Y., (2021) Effect of zinc-doped hydroxyapatite/graphene nanocomposite on the physicochemical properties and osteogenesis differentiation of 3D-printed polycaprolactone scaffolds for bone tissue engineering. Chemical Engineering Journal, 426, 131321. (Impact Factor: 13.27)
  2. Zarrabi, A., Zarepour, A., Khosravi, A., Alimohammadi, Z., Thakur, V.K., (2021) Synthesis of Curcumin Loaded Smart pH-Responsive Stealth Liposome as a Novel Nanocarrier for Cancer Treatment. Fibers, 9(3), 19.
  3. Makvandi, P., Ashrafizadeh, M., Ghomi, M., Najafi, M., Heydari Sheikh Hossein, H., Zarrabi, A., Mattoli, V., Varma, R.S., (2021) Injectable hyaluronic acid-based antibacterial hydrogel adorned with biogenically synthesized AgNPs-decorated multi-walled carbon nanotubes. Progress in Biomaterials, 10, 77.
  4. Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Azami, N., Hamzehlou, S., Farahani, M.V., Hushmandi, K., Ashrafizadeh, M., Khan, H., (2021) Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. Antioxidants, 10(3), 349.
  5. Vajedi, F.S., Dehghani, H., Zarrabi, A., (2021) Design and characterization of a novel pH-sensitive biocompatible and multifunctional nanocarrier for in vitro paclitaxel release. Materials Science and Engineering: C, 119, 111627.
  6. Baktash, M.S., Zarrabi, A., Avazverdi, E., Reis, N.M., (2021) Development and optimization of a new hybrid chitosan-grafted graphene oxide/magnetic nanoparticle system for theranostic applications. Journal of Molecular Liquids, 322, 114515.

Review papers

  1. Kumar, K.S.S., Girish, Y.R., Ashrafizadeh, M., Mirzaei, S., Rakesh, K.P., Gholami, M.H., Zabolian, A., Hushmandi, K., Orive, G., Kadumudi, F.B., Dolatshahi-Pirouz, A., Kumar Thakur, V., Zarrabi, A., Makvandi, P., Rangappa, K. S., (2021) AIE-featured tetraphenylethylene nanoarchitectures in biomedical application: Bioimaging, drug delivery and disease treatment. Coordination Chemistry Reviews, 447, 214135. (Impact Factor: 22.31)
  2. Reza Mohammadinejad, Vijay Sagar Madamsetty, Anuj Kumar, Mohammad Varzandeh, Ali Dehshahri, Ali Zarrabi, Fariba Sharififar, Mehdi Mohammadi, Amir Fahimipour, Seeram Ramakrishna, (2021) Trends in Food Science & Technology, 118, 887. (TOP 1% Journal)
  3. Pooyan Makvandi, Meiling Chen, Rossella Sartorius, Ali Zarrabi, Milad Ashrafizadeh, Farnaz Dabbagh Moghaddam, Jingzhi Ma, Virgilio Mattoli, Franklin R Tay, (2021) Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking, Nano Today, 40, 101279. (Impact Factor: 20.72)
  4. Zare, E.N., Agarwal, T., Zarepour, A., Pinelli, F., Zarrabi, A., Rossi, F., Ashrafizadeh, M., Maleki, A., Shahbazi, M.A., Maiti, T.K., Varma, R.S., (2021) Electroconductive multi-functional polypyrrole composites for biomedical applications. Applied Materials Today, 24, 101117. (Impact Factor: 10)
  5. Makvandi, P., Zarepour, A., Zheng, X., Agarwal, T., Ghomi, M., Sartorius, R., Zare, E.N., Zarrabi, A., Wu, A., Maiti, T.K., Smith, B.R., (2021) Non-spherical nanostructures in nanomedicine: From noble metal nanorods to transition metal dichalcogenide nanosheets. Applied Materials Today, 24, 101107. (Impact Factor: 10)
  6. Delfi, M., Sartorius, R., Ashrafizadeh, M., Sharifi, E., Zhang, Y., De Berardinis, P., Zarrabi, A., Varma, R.S., Tay, F.R., Smith, B.R., Makvandi, P., (2021) Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy. Nano Today, 38, 101119. (Impact Factor: 20.72)
  7. Zare, E.N., Zheng, X., Makvandi, P., Gheybi, H., Sartorius, R., Yiu, C.K.Y., Adeli, M., Wu, A., Zarrabi, A., Varma, R.S., Tay, F.R., (2021) Nonspherical Metal‐Based Nanoarchitectures: Synthesis and Impact of Size, Shape, and Composition on Their Biological Activity. Small, 17, 2007073. (Impact Factor: 13.27)
  8. Makvandi, P., Josic, U., Delfi, M., Pinelli, F., Jahed, V., Kaya, E., Ashrafizadeh, M., Zarepour, A., Rossi, F., Zarrabi, A., Agarwal, T., (2021) Drug Delivery (Nano) Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management. Advanced Science, 2004014. (Impact Factor: 16.8)
  9. Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Ali Zarrabi, Aaron Goldman, Milad Ashrafizadeh, Gorka Orive, (2021) Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today, in press. (TOP 5% Journal)
  10. Milad Ashrafizadeh, Ali Zarrabi, Sepideh Mirzaei, Farid Hashemi, Saeed Samarghandian, Amirhossein Zabolian, Kiavash Hushmandi, Hui Li Ang, Gautam Sethi, Alan Prem Kumar, Kwang Seok Ahn, Noushin Nabavi, Haroon Khan, Pooyan Makvandi, Rajender S Varma, (2021) Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery, Food and Chemical Toxicology, 157, 112576. (TOP 10% Journal)
  11. Zia, A., Sahebdel, F., Farkhondeh, T., Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Samarghandian, S., (2021) A review study on the modulation of SIRT1 expression by miRNAs in aging and age-associated diseases. International Journal of Biological Macromolecules, 88, 52. (Impact Factor: 6.95)
  12. Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Mohammad Hossein Gholami, Ali Zarrabi, Amirhossein Zabolian, Mehrdad Hashemi, Kiavash Hushmandi, Milad Ashrafizadeh, Amir Reza Aref, Saeed Samarghandian, (2021) Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies, Biomedicine & Pharmacotherapy, 144, 112335.
  13. Saltuk B Hanay, Ali Fallah, Efsun Senturk, Zeliha Yetim, Ferdows Afghah, Hulya Yilmaz, Mustafa Culha, Bahattin Koc, Ali Zarrabi, Rajender S Varma, (2021) Exploiting urazole’s acidity for fabrication of hydrogels and ion-exchange materials. Gels, 7, 261.
  14. Ashrafizadeh, M., Mirzaei, S., Gholami, M.H., Hashemi, F., Zabolian, A., Raei, M., Hushmandi, K., Zarrabi, A., Voelcker, N.H., Aref, A.R., Hamblin, M.R., (2021) Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression. Carbohydrate Polymers, 272, 118491. (Impact Factor: 9.38)
  15. Mohammad Varzandeh, Reza Mohammadinejad, Keyvan Esmaeilzadeh-Salestani, Ali Dehshahri, Ali Zarrabi, Abbas Aghaei-Afshar, (2021) Photodynamic therapy for leishmaniasis: recent advances and future trends. Photodiagnosis and Photodynamic Therapy, 36, 102609.
  16. Usman Mir Khan, Mustafa Sevindik, Ali Zarrabi, Mohammad Nami, Betul Ozdemir, Dilara Nur Kaplan, Zeliha Selamoglu, Muzaffar Hasan, Manoj Kumar, Mohammed M Alshehri, Javad Sharifi-Rad, (2021) Oxidative Medicine and Cellular Longevity, 2021, 2713511.
  17. Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Sima Orouei, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Kiavash Hushmandi, Behzad Baradaran, Mehrdad Hashmi, Amir Reza Aref, Yavuz Nuri Ertas, Ali Zarrabi, Milad Ashrafizadeh, Saeed Samarghandian, (2021) International Journal of Biological Macromolecules, 191, 727.
  18. Ashrafizadeh, M., Mirzaei, S., Hashemi, F., Zarrabi, A., Zabolian, A., Saleki, H., Sharifzadeh, S.O., Soleymani, L., Daneshi, S., Hushmandi, K., Khan, H., (2021) New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomedicine & Pharmacotherapy, 141, 111824. (Impact Factor: 6.52)
  19. Atefeh Zarepour, Sara Hooshmand, Aylin Gökmen, Ali Zarrabi, Ebrahim Mostafavi, (2021) Spinal cord injury management through the combination of stem cells and implantable 3d bioprinted platforms. Cells, 10, 3189.
  20. Aghamiri, S., Zandsalimi, F., Raee, P., Abdollahifar, M.A., Tan, S.C., Low, T.Y., Bandehpour, M., Najafi, S., Ashrafizadeh, M., Zarrabi, A., Ghanbarian, H., (2021) Antimicrobial peptides as potential therapeutics for breast cancer. Pharmacological Research, 171, 105777. (Impact Factor: 7.65)
  21. Sepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Masoud Delfi, Haroon Khan, Milad Ashrafizadeh, Gautam Sethi, Alan Prem Kumar, (2021) Pre-clinical and clinical applications of small interfering rnas (Sirna) and co-delivery systems for pancreatic cancer therapy. Cells, 10, 3348.
  22. Zha, G.F., Preetham, H.D., Rangappa, S., Kumar, K.S.S., Girish, Y.R., Rakesh, K.P., Ashrafizadeh, M., Zarrabi, A., Rangappa, K.S., (2021) Benzimidazole analogues as efficient arsenals in war against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies. Bioorganic chemistry, 115, 105175. (Impact Factor: 5.27)
  23. Mirzaei, S., Abadi, A.J., Gholami, M.H., Hashemi, F., Zabolian, A., Hushmandi, K., Zarrabi, A., Entezari, M., Aref, A.R., Khan, H., Ashrafizadeh, M., (2021) The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets. European Journal of Pharmacology, 908, 174344. (Impact Factor: 4.4)
  24. Nazanin Vaziri, Laleh Shariati, Ali Zarrabi, Ali Farazmand, Shaghayegh Haghjooy Javanmard, (2021) Cancer-Associated Fibroblasts Regulate the Plasticity of Breast Cancer Stemness through the Production of Leukemia Inhibitory Factor. Life, 11, 1298.
  25. Mirzaei, S., Gholami, M.H., Zabolian, A., Saleki, H., Farahani, M.V., Hamzehlou, S., Far, F.B., Sharifzadeh, S.O., Samarghandian, S., Khan, H., Aref, A.R., Ashrafizadeh, M., Zarrabi, A., Sethi, G., (2021) Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacological Research, 171, 105759. (Impact Factor: 7.65)
  26. Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Ranjbar, A., Saleh, S.H.S., Bagherian, M., omid Sharifzadeh, S., Hushmandi, K., Liskova, A., (2021) Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?. Cancer Letters, 509, 63. (Impact Factor: 8.67)
  27. Soleymani, L., Zarrabi, A., Hashemi, F., Zabolian, A., Banihashemi, S.M., Moghadam, S.S., Hushmandi, K., Samarghandian, S., Ashrafizadeh, M., Khan, H., (2021) Role of ZEB family members in proliferation, metastasis and chemoresistance of prostate cancer cells: Revealing signaling networks. Current Cancer Drug Targets, 21, 749.
  28. Ashrafizadeh, M., Mirzaei, S., Hushmandi, K., Rahmanian, V., Zabolian, A., Raei, M., Farahani, M.V., Goharrizi, M.A.S.B., Khan, H., Zarrabi, A., Samarghandian, S., (2021) Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects. Life Sciences, 278, 119649.
  29. Jayaraman, K., Sivakumar, P.M., Zarrabi, A., Sivakumar, R., Jeyakumar, S., (2021) Combustion Characteristics of Nanoaluminium-Based Composite Solid Propellants: An Overview. Journal of Chemistry, 2021, 5520430.
  30. Ashrafizadeh, M., Zarrabi, A., Orouei, S., Zabolian, A., Saleki, H., Azami, N., Bejandi, A.K., Mirzaei, S., Janaghard, M.N., Hushmandi, K. and Nabavi, N., (2021) Interplay between SOX9 transcription factor and microRNAs in cancer. International Journal of Biological Macromolecules, 183, 681.
  31. Mirzaei, S., Gholami, M.H., Hashemi, F., Zabolian, A., Hushmandi, K., Rahmanian, V., Entezari, M., Girish, Y.R., Kumar, K.S.S., Aref, A.R., Makvandi, P., Ashrafizadeh, M., Zarrabi, A., Khan, H., (2021) Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy. Life Sciences, 277, 119430.
  32. Mirzaei, S., Mohammadi, A.T., Gholami, M.H., Hashemi, F., Zarrabi, A., Zabolian, A., Hushmandi, K., Makvandi, P., Samec, M., Liskova, A., Kubatka, P., (2021) Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance. Pharmacological research, 167, 105575.
  33. Ashrafizaveh, S., Ashrafizadeh, M., Zarrabi, A., Husmandi, K., Zabolian, A., Shahinozzaman, M., Aref, A.R., Hamblin, M.R., Nabavi, N., Crea, F., Wang, Y., (2021) Long non-coding RNA in the doxorubicin resistance of cancer cells. Cancer Letters, 508, 104.
  34. Ashrafizadeh, M., Gholami, M.H., Mirzaei, S., Zabolian, A., Haddadi, A., Farahani, M.V., Kashani, S.H., Hushmandi, K., Najafi, M., Zarrabi, A., Ahn, K.S., (2021) Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: new insight to proliferation and metastasis. Life sciences, 270, 119006.
  35. Mirzaei, S., Zarrabi, A., Asnaf, S.E., Hashemi, F., Zabolian, A., Hushmandi, K., Raei, M., Goharrizi, M.A.S.B., Makvandi, P., Samarghandian, S., Najafi, M., (2021) The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators. Life sciences, 268, 119005.
  36. Baghaei, S., Khorasani, M.T., Zarrabi, A., Moshtaghian, J., (2021) Preparation and Determination of the Characteristics of Hydrogel Membrane of Poly-Vinyl Alchol, Starch and Chitosan. Journal of Advanced Materials and Processing, 9(1), 11.
  37. Mirzaei, S., Hushmandi, K., Zabolian, A., Saleki, H., Torabi, S.M.R., Ranjbar, A., SeyedSaleh, S., Sharifzadeh, S.O., Khan, H., Ashrafizadeh, M., Zarrabi, A., (2021) Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules, 26(8), 2382.
  38. Hussain, Y., Mirzaei, S., Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Khan, H., Daglia, M., (2021) Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance. Cancers, 13(7), 1602.
  39. Sharafati-Chaleshtori, R., Nickdasti, A., Mortezapour, E., Pourhanifeh, M.H., Ghazanfari, M., Movahedpour, A., Khatami, A., Ashrafizadeh, M., Zarrabi, A., Mahabady, M.K., Khan, H., (2021) Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review. Current Molecular Medicine, 21, 832.
  40. Mirzaei, S., Khaksary Mahabady, M., Zabolian, A., Abbaspour, A., Fallahzadeh, P., Noori, M., Hashemi, F., Hushmandi, K., Daneshi, S., Kumar, A.P., Aref, A.R., Samarghandian, S., Makvandi, P., Khan, H., Hamblin, M.R., Ashrafizadeh, M., Zarrabi, A., (2021) Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems. Life Sciences, 275, 119368.
  41. Liskova, A., Samec, M., Koklesova, L., Samuel, S.M., Zhai, K., Al-Ishaq, R.K., Abotaleb, M., Nosal, V., Kajo, K., Ashrafizadeh, M., Zarrabi, A., (2021) Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomedicine & Pharmacotherapy, 138, 111430.
  42. Ashrafizade, M., Delfi, M., Hashemi, F., Zabolian, A., Saleki, H., Bagherian, M., Azami, N., Farahani, M.V., Sharifzadeh, S.O., Hamzehlou, S. Hushmandi, K., Makvandi, P., Zarrabi, A., Hamblin, R. M., Varma, R.S., (2021) Biomedical application of Chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydrate Polymers, 260, 117809.
  43. Abadi, A.J., Zarrabi, A., Hashemi, F., Zabolian, A., Najafi, M., Entezari, M., Hushmandi, K., Aref, A.R., Khan, H., Makvandi, P., Ashrafizaveh, S., (2021) The role of SOX family transcription factors in gastric cancer. International Journal of Biological Macromolecules, 180, 608.
  44. Ashrafizadeh, M., Shahinozzaman, M., Orouei, S., Zarrin, V., Hushmandi, K., Hashemi, F., Kumar, A., Samarghandian, S., Najafi, M., Zarrabi, A., (2021) Crosstalk of long non-coding RNAs and EMT: Searching the missing pieces of an incomplete puzzle for lung cancer therapy. Current Cancer Drug Targets, 21, 640.
  45. Fallahi, F., Borran, S., Ashrafizadeh, M., Zarrabi, A., Pourhanifeh, M.H., Mahabady, M.K., Sahebkar, A., Mirzaei, H., (2021) Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials. Molecular Immunology, 130, 20.
  46. Bhia, M., Motallebi, M., Abadi, B., Zarepour, A., Pereira-Silva, M., Saremnejad, F., Santos, A.C., Zarrabi, A., Melero, A., Jafari, S.M., Shakibaei, M., (2021) Naringenin Nano-Delivery Systems and Their Therapeutic Applications. Pharmaceutics, 13(2), 291.
  47. Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Hashemi, F., Moghadam, E.R., Owrang, M., Hashemi, F., Makvandi, P., Goharrizi, M.A.S.B., Najafi, M., Khan, H., (2021) Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators. Cellular Signalling, 78, 109871.
  48. Ashrafizadeh, M., Zarrabi, A., Orouei, S., Hushmandi, K., Hakimi, A., Zabolian, A., Daneshi, S., Samarghandian, S., Baradaran, B., Najafi, M., (2021) MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity. European Journal of Pharmacology, 892, 173660.
  49. Mirzaei, S., Fekri, H.S., Hashemi, F., Hushmandi, K., Mohamamdinejad, R., Ashrafizadeh, M., Zarrabi, A., Garg, M., (2021) Venom peptides in cancer therapy: An updated review on cellular and molecular aspects. Pharmacological Research, 164, 105327.
  50. Abadi, A.J., Zarrabi, A., Gholami, M.H., Mirzaei, S., Hashemi, F., Zabolian, A., Entezari, M., Hushmandi, K., Ashrafizadeh, M., Khan, H., Kumar, A.P., (2021) Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules, 11(2), 304.
  51. Kumar, P.M.S., Prabhawathi, V., Zarrabi, A., Akthar, S., Prabhakar, P.K., (2021) Current Trends in the Therapeutic Strategies for Diabetes Management. Current medicinal chemistry, 28, 4616.
  52. Mirzaei, B., Zarrabi, A., Noorbakhsh, A., Amini, A., Makvandi, P., (2021) A reduced graphene oxide-β-cyclodextrin nanocomposite-based electrode for electrochemical detection of curcumin. RSC Advances, 11(14), 7862.
  53. Hashemi, F., Zarrabi, A., Zabolian, A., Saleki, H., Farahani, M.V., Sharifzadeh, S.O., Ghahremaniyeh, Z., Bejandi, A.K., Hushmandi, K., Ashrafizadeh, M., Khan, H., (2021) Novel strategy in breast cancer therapy: Revealing the bright side of ginsenosides. Current Molecular Pharmacology, 14, 1093.
  54. Mirzaei, S., Gholami, M.H., Mahabady, M.K., Nabavi, N., Zabolian, A., Banihashemi, S.M., Haddadi, A., Entezari, M., Hushmandi, K., Makvandi, P. Samarghandian, S., Zarrabi, A., Ashrafizadeh, M., Khan, H., (2021) Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. Biomedicine & Pharmacotherapy, 133, 111077.

 2020

 Original papers    

  1. Esmaeili, Y., Bidram, E., Zarrabi, A., Amini, A., Cheng, C., (2020) Graphene oxide and its derivatives as promising In-vitro bio-imaging platforms. Scientific Reports (Nature Publisher Group), 10(1), 1.
  2. Esmaeili, Y., Zarrabi, A., Mirahmadi-Zare, S.Z., Bidram, E., (2020) Hierarchical multifunctional graphene oxide cancer nanotheranostics agent for synchronous switchable fluorescence imaging and chemical therapy. Microchim Acta, 187, 553.
  3. Heydari Sheikh Hossein, H., Jabbari, I., Zarepour, A., Zarrabi, A., Ashrafizadeh, M., Taherian, A., Makvandi, P., (2020). Functionalization of Magnetic Nanoparticles by Folate as Potential MRI Contrast Agent for Breast Cancer Diagnostics. Molecules, 25, 4053.
  4. Jahed, V., Vasheghani-Farahani, E., Bagheri, F., Zarrabi, A., Halkjær Jensen, H., Larsen, K.L., (2020). Quantum dots-βcyclodextrin-histidine labeled human adipose stem cells-laden chitosan hydrogel for bone tissue engineering. Nanomedicine: Nanotechnology, Biology, and Medicine, in press.
  5. Ghorghi, M., Rafienia, M., Nasirian, V., Bitaraf, F. S., Gharravi, A. M., & Zarrabi, A. (2020). Electrospun captopril‐loaded PCL‐carbon quantum dots nanocomposite scaffold: Fabrication, characterization, and in vitro studies. Polymers for Advanced Technologies, in press. 
  6. Ahmadi-Kashani, M., Dehghani, H., Zarrabi, A., (2020). A biocompatible nanoplatform formed by MgAl-layered double hydroxide modified Mn3O4/N-graphene quantum dot conjugated-polyaniline for pH-triggered release of doxorubicin. Materials Science and Engineering: C, 114, 111055. 
  7. Khorrami, S., Kamali, F., Zarrabi, A., (2020). Bacteriostatic activity of aquatic extract of black peel pomegranate and silver nanoparticles biosynthesized by using the extract. Biocatalysis and Agricultural Biotechnology, 25, 101620.
  8. Jafari, S., Tavakoli, M.B., Zarrabi, A., (2020). Lomustine Loaded Superparamagnetic Iron Oxide Nanoparticles Conjugated with Folic Acid for Treatment of Glioblastoma Multiforma (GBM). Iranian Journal of Pharmaceutical Research, in press.
  9. Rajabi, N., Emadi, R., Zarrabi, A., Mokhtari, H.R., Salehi, S., (2020). An adhesive and injectable nanocomposite hydrogel of thiolated gelatin/ gelatin methacrylate /Laponite as a potential surgical sealant. Journal of Colloid and Interface Science, 564, 155-169.
  10. Rafati, A., Zarrabi, A., Gill, P., (2020). DNA Nanotubes Coupled with Magnetic Nanoparticles as a Platform for Colorimetric Biosensors. Nanomedicine Research Journal, 5(1), 63. 
  11. Jafari, S., Cheki, M., Tavakoli, M.B., Zarrabi, A., Ghazikhanlu Sani, K., Afzalipour, R., (2020). Investigation of Combination Effect Between 6 MV X-Ray Radiation and Polyglycerol Coated Superparamagnetic Iron Oxide Nanoparticles on U87-MG Cancer Cells. Journal of Biomedical Physics & Engineering, 10(1), 15.
  12. Rafati, A., Zarrabi, A., Gill, P., (2020). Origami-Induced Alignment of MNP Inside of DNA Nano-tubes. International Journal of Medical Nano Research, 7(1), 31.

 Review   

  1. Dehshahri, A., Kumar, A., Madamsetty, V.S., Uzieliene, I., Tavakol, S., Azedi, F., Fekri, H.S., Zarrabi, A., Mohammadinejad, R., Thakur, V.K., (2020) New Horizons in Hydrogels for Methotrexate Delivery. Gels, 7(1), 2.
  2. Aghaei, M., Dastghaib, S., Aftabi, S., Aghanoori, M.R., Alizadeh, J., Mokarram, P., Mehrbod, P., Ashrafizadeh, M., Zarrabi, A., McAlinden, K.D., Eapen, M.S., (2020) The ER Stress/UPR Axis in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Life, 11(1), 1.
  3. Ashrafizadeh, M., Samarghandian, S., Hushmandi, K., Zabolian, A., Shahinozzaman, M., Saleki, H., Esmaeili, H., Raei, M., Entezari, M., Zarrabi, A., Najafi, M., (2020) Quercetin in attenuation of ischemic/reperfusion injury: A review. Current Molecular Pharmacology.
  4. Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Zarrin, V., Moghadam, E.R., Hashemi, F., Makvandi, P., Samarghandian, S., Khan, H., Hashemi, F., Najafi, M., (2020) Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review. Frontiers in Pharmacology, 11, 1785.
  5. Ashrafizadeh, M., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Bagherian, M., Azami, N., Bejandi, A.K., Hushmandi, K., Ang, H.L., Makvandi, P., (2020) Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity. Pharmaceutics, 12(11), 1084.
  6. Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Hashemi, F., Rahmani Moghadam, E., Raei, M., Kalantari, M., Tavakol, S., Mohammadinejad, R., Najafi, M., Tay, F.R., (2020) Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS combinatorial science, 22(12), 669.
  7. Ashrafizadeh, M., Bakhoda, M.R., Bahmanpour, Z., Ilkhani, K., Zarrabi, A., Makvandi, P., Khan, H., Mazaheri, S., Darvish, M., Mirzaei, H., (2020) Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Frontiers in Chemistry, 8, 1.
  8. Moghadam, E.R., Ang, H.L., Asnaf, S.E., Zabolian, A., Saleki, H., Yavari, M., Esmaeili, H., Zarrabi, A., Ashrafizadeh, M., Kumar, A.P., (2020) Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules, 10(10), 1374.
  9. Ashrafizadeh, M., Zarrabi, A., Orouei, S., Saberifar, S., Salami, S., Hushmandi, K., Najafi, M., (2020) Recent advances and future directions in anti‐tumor activity of cryptotanshinone: A mechanistic review. Phytotherapy Research, 35(1), 155.
  10. Ashrafizadeh, M., Zarrabi, A., Hashemipour, M., Vosough, M., Najafi, M., Shahinozzaman, Md., Hushmandi, K., Khan, H., Mirzaei, H., (2020). Sensing the scent of death: Modulation of microRNAs by curcumin in gastrointestinal cancers. Pharmacological Research, in press.
  11. Makvandi, P., Iftekhar, S., Pizzetti, F., Zarepour, A., Nazarzadeh Zare, E., Ashrafizadeh, M., Agarwal, T., Padil, V.V.T., Mohammadinejad, R., Sillanpaa, M., Maiti, T.K., Perale, G., Zarrabi, A., Rossi, F., (2020). Functionalization of polymers and nanomaterials for water treatment, food packaging, textile and biomedical applications: a review. Environmental Chemistry Letters. in press.
  12. Mohammadinejad, R., Dehshahri, A., Madamsetty, V.S., Zahmatkeshan, M., Tavakol, S., Makvandi, P., Khorsandi, D., Pardakhty, Ashrafizadeh, M., Ghasemipour Afshar, E., Zarrabi, A., (2020). In vivo gene delivery mediated by non-viral vectors for cancer therapy. Journal of Controlled Release, 325, 249.
  13. Ashrafizadeh, M., Najafi, M., Makvandi, P., Zarrabi, A., Farkhondeh, T., Samarghandian, S., (2020). Versatile role of curcumin and its derivatives in lung cancer therapy. Journal of Cellular Physiology, in press. 
  14. Ghasemipour Afshar, E., Zarrabi, A., Dehshahri, A., Ashrafizadeh, M., Dehghannoudeh, G., Behnam, B., Mandegary, A., Pardakhty, A., Mohammadinejad, R., Tavakol, S., (2020). Graphene as a promising multifunctional nanoplatform for glioblastoma theranostic applications. FlatChem, in press. 
  15. Durak, S., Esmaeili Rad, M., Yetisgin, A.A., Sutova, H.E., Kutlu, O., Cetinel, S., Zarrabi, A., (2020). Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects. Nanomaterials, 10(6), 1191.
  16. Ashrafizadeh, M., Zarrabi, A., Najafi, M., Samarghandian, S., Mohammadinejad, R., Ahn, K.S., (2020). Resveratrol targeting tau proteins, amyloid‐beta aggregations, and their adverse effects: An updated review. Phytotherapy Research, in press. 
  17. Ashrafizadeh, M., Zarrabi, A., Orouei, S., Zarrin, V., Rahmani Moghadam, E., Zabolian, A., Mohammadi, S., Hushmandi, K., Gharehaghajlou, Y., Makvandi, P., Najafi, M., Mohammadinejad, R., (2020). STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects. Biology, 9(6), 126.
  18. Ashrafizadeh, M., Zarrabi, A., Samarghandian, S., Najafi, M., (2020). PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?. European Journal of Pharmacology, in press. 
  19. Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Zarrin, V., Moghadam, ER., Zabolian, A., Tavakol, S., Samarghandian, Najafi, M., (2020). PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs. Life Sciences, 256, 117899. 
  20. Nasery, M.M., Abadi, B., Poormoghadam, D., Zarrabi, A., Keyhanvar, P., Khanbabaei, H., Ashrafizadeh, M., Mohammadinejad, R., Tavakol, S., Sethi, G., (2020). Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review. Molecules, 25(3), 689. 
  21. Ashrafizadeh, M., Zarrabi, A., Saberifar, S., Hashemi, F., Hushmandi, K., Hashemi, F., Rahmani Moghadam, E., Mohammadinejad, R., Najafi, M., Garg, M., (2020). Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines, 8, 110.
  22. Shakeri, S., Ashrafizadeh, M., Zarrabi, A., Roghanian, R., Ghasemipour Afshar, E., Pardakhty, A., Mohammadinejad, R., Kumar, A., and Thakur, V.K., (2020). Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics. Biomedicines, 8, 13.
  23. Ashrafizadeh, M., Ahmadi, Z., Mohamadi, N., Zarrabi, A., Abasi, S., Dehghannoudeh, G., Tamaddondoust, RN., Khanbabaei, H., Mohammadinejad, R., Thakur, VK., (2020). Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics. International Journal of Biological Macromolecules, 145, 282-300.
  24. Zarrabi, A., Alipoor Amro Abadi, M., Khorasani, S., Mohammadabadi, M.R., Jamshidi, A., Torkaman, S., Taghavi, E., Mozafari, M., Rasti, B., (2020). Nanoliposomes and Tocosomes as Multifunctional Nanocarriers for the Encapsulation of Nutraceutical and Dietary Molecules. Molecules, 25, 638.
  25. Delfi, M., Ghomi, M., Zarrabi, A., Mohammadinejad, R., Taraghdari, Z. B., Ashrafizadeh, M., Nazarzadeh Zare, E., Agarwal, T., Padil, V., Mokhtari, B., Rossi, F., Perale, G., Sillanpaa, M., Borzacchiello, A., Maiti, T., & Makvandi, P (2020). Functionalization of Polymers and Nanomaterials for Biomedical Applications: Antimicrobial Platforms and Drug Carriers. Prosthesis, 2(2), 117-139.
  26. Najafi, M., Tavakol, S., Zarrabi, A., & Ashrafizadeh, M. (2020). Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review. Archives of Physiology and Biochemistry, 1-15.
  27. Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Hashemi, F., Hashemi, F., Samarghandian, S., & Najafi, M. (2020). MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer. Life sciences, 117973.
  28. . Ashrafizadeh, M., Zarrabi, A., Hashemi, F., Moghadam, E. R., Hashemi, F., Entezari, M., Hushmandi, K., Mohammadinejad, R., & Najafi, M. (2020). Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sciences, 117984.
  29. Ashrafizadeh, M., Najafi, M., Orouei, S., Zabolian, A., Saleki, H., Azami, N., Sharifi, N., Hushmandi, K., Zarrabi, A., & Ahn, K. S. (2020). Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities. Biomedicines, 8(8), 261.
  30. Ashrafizadeh, M., Najafi, M., Ang, H. L., Moghadam, E. R., Mahabady, M. K., Zabolian, A., Jafaripour, L., Bejandi, A., Hushmandi, K., Saleki, H., Zarrabi, A., & Kumar A. (2020). PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines, 8(8), 264.
  31. Ashrafizadeh, M., Hushmandi, K., Hashemi, M., Akbari, M. E., Kubatka, P., Raei, M., Koklesova, L., Shahinozzaman, M., Mohammadinejad, R., Najafi, M., Sethi, G., Prem Kumar, A., & Zarrabi , A. (2020). Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Biomolecules, 10(8), 1159.
  32. Ashrafizadeh, M., Taeb, S., Hushmandi, K., Orouei, S., Shahinozzaman, M., Zabolian, A., Moghadam, E., Raei, M., Zarrabi, A., Khan, H.,  & Najafi, M. (2020). Cancer and SOX proteins: New insight into their role in ovarian cancer progression/inhibition. Pharmacological research, 105159.
  33. Makvandi, P., Ghomi, M., Ashrafizadeh, M., Tafazoli, A., Agarwal, T., Delfi, M., Akhtari, J., NazarzadeZare, E., Padil, V., Zarrabi, A., Pourreza, N., Miltyk, W., & Maiti, T. (2020). A review on advances in graphene-derivative/polysaccharide bionanocomposites: Therapeutics, Pharmacogenomics and Toxicity. Carbohydrate Polymers, 116952.
  34. Ashrafizadeh, M., Hushmandi, K., Rahmani Moghadam, E., Zarrin, V., Hosseinzadeh Kashani, S., Bokaie, S., Najafi, M., Tavakol, S., Mohammadinejad, R., Nabavi, N., Hsieh, C., Zarepour, A., Nazarzadeh Zare, E., Zarrabi, A., & Macvandi, P. (2020). Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer. Bioengineering, 7(3), 91.
  35. Ashrafizadeh, M., Ang, H. L., Moghadam, E. R., Mohammadi, S., Zarrin, V., Hushmandi, K., Samarghandian, S., Zarrabi, A., Najafi, M., Mohammadinejad, R.,& Kumar, A. P. (2020). MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy. Biomolecules, 10(7), 1040.
  36. Makvandi, P., Ghomi, M., Padil, V. V., Shalchy, F., Ashrafizadeh, M., Askarinejad, S., Pourreza, N., Zarrabi, A., Zare., E., Kooti, M., Mokhtari, B., Borzacchiello, A., & Mokhtari, B.(2020). Biofabricated Nanostructures and Their Composites in Regenerative Medicine. ACS Applied Nano Materials, 3(7), 6210-6238.
  37. Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Kalantari, M., Mohammadinejad, R., Javaheri, T., & Sethi, G. (2020). Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance. International Journal of Molecular Sciences, 21(11), 4002.
  38. Rajabi, N., Kharaziha, M., Emadi, R., Zarrabi, A., Mokhtari, H., & Salehi, S. (2020). An adhesive and injectable nanocomposite hydrogel of thiolated gelatin/gelatin methacrylate/Laponite® as a potential surgical sealant. Journal of Colloid and Interface Science, 564, 155-169.

 Book chapter

  1. Dehghani, P., Jahed, V. and Zarrabi, A., (2020) Advances and challenges toward neural regenerative medicine. In Neural Regenerative Nanomedicine (1-23). Academic Press.

 

2019

 Original papers   

  1. Abolhasani, A., Biria, D., Abolhasani, H., Zarrabi, A., Komeili, T., (2019). Investigation of the Role of Glucose Decorated Chitosan and PLGA Nanoparticles as Blocking Agents to Glucose Transporters of Tumor Cells. International Journal of Nanomedicine, 14: 9535–9546.
  2. Khorrami, S., Zarepour, A., Zarrabi, A., (2019). Green synthesis of silver nanoparticles at low temperature in a fast pace with unique DPPH radical scavenging and selective cytotoxicity against MCF-7 and BT-20 tumor cell lines. Biotechnology Reports, e00393.
  3. Perumal, V., Sivakumar, P.M., Zarrabi, A., Muthupandian, S., Vijayaraghavalu, S., Sahoo, K., Das, A., Das S., Payyappilly, S.S., Das, S., (2019). Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis. Journal of Photochemistry and Photobiology B: Biology, 199, 111630.
  4. Jahed, V., Vasheghani-Farahani, E., Bagheri, F., Zarrabi, A., Fink, T., Lambertsen, Larsen K., (2019). Enhanced Cellular Uptake Of Phenamil Through Inclusion Complex With Histidine Functionalized β-Cyclodextrin As Penetrative Osteoinductive Agent. International Journal of Nanomedicine, 14, 8221-8234.
  5. Rafati, N., Zarrabi, A., Caldera, F., Trotta, F., Ghias, N., (2019). Pyromellitic Dianhydride Crosslinked Cyclodextrin Nanosponges for Curcumin Controlled Release; Formulation, Physicochemical Characterization and Cytotoxicity Investigations. Journal of Microencapsulation, In Press.
  6. Zarepour, A., Zarrabi, A., Larsen, K., (2019). Fabricating β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy. International Journal of Nanomedicine, 14, 7017-7038.
  7. Yarjanli, Z., Ghaedi, K., Esmaeili, A., Zarrabi, A., Rahgozar, S., (2019). The antitoxic effects of quercetin and quercetin-conjugated iron oxide nanoparticles (QNPs) against H2O2-induced toxicity in PC12 cells. International Journal of Nanomedicine, 14, 6813-6830.
  8. Khorrami, S., Abdollahi, Z., Eshaghi, G., Khosravi, A., Bidram, E., Zarrabi, A., (2019). An Improved Method for Fabrication of Ag-GO Nanocomposite with Controlled Anti-Cancer and Anti-bacterial Behavior; A Comparative Study. Scientific Reports, 9, 9167.
  9. Khorrami, S., Jafari Najafabadi, F., Zarepour, A., Zarrabi, A., (2019). Is Astragalus gossypinus Honey a Natural Antibacterial and Cytotoxic Agent? An Investigation on A. gossypinusHoney Biological Activity and Its Green Synthesized Silver Nanoparticles. Bionanoscience, 9, 603-610.
  10. Katebi, S., Esmaeili, A., Ghaedi, K., and Zarrabi, A., (2019). Superparamagnetic iron oxide nanoparticles combined with NGF and quercetin promote neuronal branching morphogenesis of PC12 cells. International Journal of Nanomedicine, 14, 2157-2169.
  11. Saudi, A., Rafienia, M., Kharazi, A.Z., Salehi, H., Zarrabi, A., and Karevan, M., (2019). Design and Fabrication of Poly(glycerol sebacate)-Based Fibers for Neural Tissue Engineering: Synthesis, Electrospinning, and Characterization. Polymer for Advanced Technologies, 30, 1427-1440.
  12. Enayati, M., Nemati, A., Zarrabi, A., and Shokrgozar, M.A., (2019). The role of oxygen defects in magnetic properties of gamma-irradiated reduced graphene oxide. Journal of Alloys and Compounds, 784, 134-148.

Review

  1. Bidram, E., Esmaeili, Y., Ranji-Burachaloo, H., Al-Zaubai, N., Zarrabi, A., Stewart, A., Dunstan, D.E., (2019). A concise review on cancer treatment methods and delivery systems. Journal of Drug Delivery Science and Technology, In Press.
  2. Sivakumar, P., Islami, M., Zarrabi, A., Khosravi, A., Peimanfard, S., (2019). Polymer-graphene nanoassemblies and their applications in cancer theranostics. Anticancer Agents in Medicinal Chemistry, In Press.
  3. Moradi, M., Abdolhosseini, M., Zarrabi, A., Joharim B., (2019). A review on application of Nano-structures and Nano-objects with high potential for managing different aspects of bone malignancies. Nano-Structures & Nano-Objects, 19, 100348.
  4. Sivakumar, P., Peimanfard, S., Zarrabi, A., Khosravi, A., Islami, M., (2019). Cyclodextrin-Based Nanosystems as Drug Carriers for Cancer Therapy. Anticancer Agents in Medicinal Chemistry, In Press.

 

2018

Original papers   

  1. Bidram, E., Sulistio, A., Cho, H.J., Amini, A., Harris, T., Zarrabi, A., Qiao, G.G., Stewart, A., and Dunstan, D.E., (2018). Targeted Graphene Oxide Networks: Cytotoxicity and Synergy with Anticancer Agents. ACS Applied Materials & Interfaces, 10, 43523-43532.
  2. Khorrami, S., Zarrabi, A., Khaleghi, M., Danaei, M., Mozafari, M.R., (2018). Selective cytotoxicity of green synthesized silver nanoparticles against MCF-7 tumor cell line with enhanced antioxidant and antimicrobial properties. International Journal of Nanomedicine, 13, 8013-8024.
  3. Islami, M., Zarrabi, A., Tada, S., Kawamoto, M., Isoshima, T., Ito, Y., (2018). Quercetin Controlled release from high-capacity loading hyperbranched polyglycerol-functionalized graphene oxide. International Journal of Nanomedicine, 13, 6059-6071.
  4. Fakhimikabir, H., Tavakoli, M.B., Zarrabi, A., Amouheidari, A., Rahgozar, S., (2018). Could FA-PG-SPIONs act as a hyperthermia sensitizing agent? An in vitro study. Journal of Thermal Biology, 78, 73-83.
  5. Enayati, M., Nemati, A., Zarrabi, A., Shokrgozar, M.A., (2018). Reduced Graphene Oxide: An Alternative for Magnetic Resonance Imaging Contrast Agent. Materials Letters, 233, 363-366.
  6. Jafari, S., Cheki, M., Tavakoli, M.B., Zarrabi, A., Ghazikhanlu Sani, K., Afzalipour, R., (2018). Investigation of Combination Effect Between 6 MV X Ray Radiation and Polyglycerol Coated Superparamagnetic Iron Oxide Nanoparticles on U87-MG Cancer Cells. Journal of Biomedical Physics and Engineering, in press.
  7. Fakhimikabir, H., Tavakoli M.B., Zarrabi, A., Amouheidar, A., Rahgozar, S., (2018).  The role of folicacid-conjugated polyglycerol coated iron oxide nanoparticles on radiosensitivity with clinical electron beam (6MeV) on human cervical carcinoma cell line: in vitro study. Journal of Photochemistry and Photobiology B: Biology, 182, 71-76.
  8. Rafati, A., Zarrabi, A., Abediankenari, S., Aarabi, M., Gill, P., (2018). Sensitive colorimetric assay using insulin G-quadruplex aptamer arrays on DNA nanotubes coupled with magnetic nanoparticles. Royal Society Open Science, 5, 171835-171844.
  9. Assadi, Z., Emtiazi, G., & Zarrabi, A., (2018). Hyperbranched polyglycerol coated on copper oxide nanoparticles as a novel core-shell nano-carrier hydrophilic drug delivery model. Journal of Molecular Liquids, 250, 375-380.
  10. Assadi, Z., Emtiazi, G., & Zarrabi, A., (2018). Novel synergistic activities of tetracycline copper oxide nanoparticles integrated into chitosan micro particles for delivery against multiple drug resistant strains: Generation of reactive oxygen species (ROS) and cell death. Journal of Drug Delivery Science and Technology, 44, 65-70.
  11. Mostaghasi, E., Zarepour, A., & Zarrabi, A., (2018). Folic Acid Armed Fe3O4-HPG Nanoparticles as a Safe Nano Vehicle for Biomedical Theranostics. Journal of the Taiwan Institute of Chemical Engineers, 82, 33-41.
  12. Assadi, Z., Emtiazi, G., & Zarrabi, A. (2018). Opto-electronic and activity investigations of mono-dispersed nanostructure copper oxide prepared by a novel method: reduction of reactive oxygen species (ROS). Journal of Materials Science: Materials in Electronics, 29, 1798-1807.

 

2017

Original papers  

  1. Baghaie, S., Khorasani, M.T., Zarrabi, A., & Moshtaghian, J. (2017). Wound healing properties of PVA/starch/chitosan hydrogel membranes with nano Zinc oxide as antibacterial wound dressing material. Journal of Biomaterials Science, Polymer Edition, 28, 2220-2241.
  2. Imanifard, S., Zarrabi, A., Zarepour, A., Jafari, M., Khosravi, A., & Razmjou, A. (2017). Nanoengineered Thermoresponsive Magnetic Nanoparticles for Drug Controlled Release. Macromolecular Chemistry and Physics, 218(23), 1700350-1700357.
  3. Heydari Sheikh Hossein, H., Zarrabi, A., & Zarepour, A. (2017). Design and Construction of Curcumin – Loaded Targeted Iron Oxide Nanoparticles for Cancer Treatment. Journal of Babol University of Medical Sciences, 19, 64-70.
  4. Emami, N., Razmjou, A., Noorisafa, F., Korayem, A. H., Zarrabi, A., & Ji, C. (2017). Fabrication of smart magnetic nanocomposite asymmetric membrane capsules for the controlled release of nitrate. Environmental Nanotechnology, Monitoring & Management, 8, 233-243.
  5. Emtiazi, G., Zohrabi, T., Lee, L.Y., Habibi, N., & Zarrabi, A. (2017). Covalent diphenylalanine peptide nanotube conjugated to folic acid/magnetic nanoparticles for anti-cancer drug delivery. Journal of Drug Delivery Science and Technology, 41, 90-98.
  6. Yarjanli, Z., Ghaedi, K., Esmaeili, A., Rahgozar, S. & Zarrabi. A. (2017). Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neuroscience, 18, 51-62.
  7. Rafati, A., Zarrabi, A. & Gill, P. (2017). Fabrication of DNA nanotubes with an array of exterior magnetic nanoparticles. Materials Science and Engineering: C, 79, 216-220.

 

Books

  1. Zarepour A., Zarrabi, A., Khosravi, A. (2017). SPIONs as Nano-Theranostics Agents, Springer, Singapore.

 

2016

Original papers  

  1. Zohrabi, T., Habibi, N., Zarrabi, A., Fanaei, M., & Lee, L. Y. (2016). Diphenylalanine peptide nanotubes self‐assembled on functionalized metal surfaces for potential application in drug‐eluting stent.Journal of Biomedical Materials Research Part A, 104(9), 2280-2290.
  2. Mohammadi, Z. A., Aghamiri, S. F., Zarrabi, A., & Talaie, M. R. (2016). Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior. Current drug delivery, 13(7), 1065-1070.

 

Review

  1. Moghanjoughi, A. A., Khoshnevis, D., & Zarrabi, A. (2016). A concise review on smart polymers for controlled drug release.Drug delivery and translational research, 6(3), 333-340.

 

Books

  1. Amiri, A., Zare-Zardini, H., Shanbedi, M., Kazi, S. N., Taheri-Kafrani, A., Chew, B. T., & Zarrabi, A. (2016). Microbial toxicity of different functional groups-treated carbon nanotubes.Surface Chemistry of Nanobiomaterials, 33.

 

2015

Original papers

  1. Zarrabi, A., & Vossoughi, M. (2015). Paclitaxel/β-CD-g-PG inclusion complex: an insight into complexation thermodynamics and guest solubility. Journal of Molecular Liquids, 208, 145-150.
  2. Mohammadi, Z. A., Aghamiri, S. F., Zarrabi, A., & Talaie, M. R. (2015). A comparative study on non-covalent functionalization of carbon nanotubes by chitosan and its derivatives for delivery of doxorubicin.Chemical Physics Letters, 642, 22-28.
  3. Moeiniafshari, A. A., Zarrabi, A., & Bordbar, A. K. (2015). Exploring the interaction of naringenin with bovine beta-casein nanoparticles using spectroscopy.Food Hydrocolloids, 51, 1-6.
  4. Jahandar, M., Zarrabi, A., Shokrgozar, M. A., & Mousavi, H. (2015). Synthesis, characterization and application of polyglycerol coated Fe3O4 nanoparticles as a nano-theranostics agent.Materials Research Express,2(12), 125002.
  5. Mousavi, H., Movahedi, B., Zarrabi, A., & Jahandar, M. (2015). A multifunctional hierarchically assembled magnetic nanostructure towards cancer nano-theranostics.RSC Advances, 5(94), 77255-77263.
  6. Fard, A. E., Zarepour, A., Zarrabi, A., Shanei, A., & Salehi, H. (2015). Synergistic effect of the combination of triethylene-glycol modified Fe3O4 nanoparticles and ultrasound wave on MCF-7 cells.Journal of Magnetism and Magnetic Materials, 394, 44-49.

 

Books

  1. Zarrabi, A. Khosravi, A. Hashemi, “Nanomedicine: Review and Perspectives”, In “Encyclopedia of Biomedical Polymers and Polymeric Biomaterials”, CRC Press, Taylor and Francis: New York, 5393-5413, 2015.

 

2014

Original papers

  1. Jahed, V., Zarrabi, A., Bordbar, A. K., & Hafezi, M. S. (2014). NMR (1 H, ROESY) spectroscopic and molecular modelling investigations of supramolecular complex of β-cyclodextrin and curcumin.Food chemistry,165, 241-246.
  2. Zarrabi, A., Shokrgozar, M. A., Vossoughi, M., & Farokhi, M. (2014). In vitro biocompatibility evaluations of hyperbranched polyglycerol hybrid nanostructure as a candidate for nanomedicine applications.Journal of Materials Science: Materials in Medicine, 25(2), 499-506.
  3. Gavanji, S., Mohabatkar, H., Baghshahi, H., & Zarrabi, A. (2014). Bioinformatics Prediction of Interaction Silver Nanoparticles on the Disulfide Bonds of HIV-1 Gp120 Protein.International Journal of Scientific Research in Knowledge, 2(2), 67.
  4. Jahandar, A. Zarrabi, M.A. Shokrgozar, “Polymer coated magnetic nanoparticles as a novel carrier in curcumin nanomedicine”, Iranian Journal of Pharmaceutical Research, 2014, 292 (in Persian language).
  5. Jahed, A. Zarrabi, A.K.Bordbar, “Curcumin Nanomedicine; Aplications of β-Cyclodextrin in curcumin solubility enhancement”, Iranian Journal of Pharmaceutical Research, 2014, 465 (in Persian language).

2012

Original papers

  1. Zarrabi, A., Vossoughi, M., Alemzadeh, I., & Chitsazi, M. R. (2012). Monodispersed polymeric nanoparticles fabrication by electrospray atomization.International Journal of Polymeric Materials, 61(8), 611-626.
  2. Nahid, P., Vossoughi, M., Roostaazad, R., Ahmadi, M., Zarrabi, A., & Hosseini, S. M. (2012). RESEARCH NOTE PRODUCTION OF GLUCOAMYLASE BY ASPERGILLUS NIGER UNDER SOLID STATE FERMENTATION.

 

2011

Original papers

  1. Zarrabi, A., Adeli, M., Vossoughi, M., & Shokrgozar, M. A. (2011). Design and synthesis of novel polyglycerol hybrid nanomaterials for potential applications in drug delivery systems.Macromolecular bioscience, 11(3), 383-390.
  2. Nahid, P., Vossoughi, M., Azad, R. R., Ahmadi, M., Zarrabi, A., & Hosseini, S. M. (2011). THE PRODUCTION OF GLUCOAMYLASE BY ASPERGILLUS NIGER UNDER SOLID STATE CONDITIONS (RESEARCH NOTE).International Journal of Engineering-Transactions B: Applications,25(1), 1.

Before 2010

Original papers

  • Biria, D., Zarrabi, A., & Khosravi, A. (2008). The application of corrugated parallel bundle model to immobilized cells in porous microcapsule membranes.Journal of membrane science, 311(1), 159-164.

 

 

Patents

  1.  “Setup for Nanoparticle Fabrication Using Electrospray Method”, Patent No.:40914, June 2007.
  2. “Spherical PLGA Nanoparticles Fabricated by Using High Voltages”, Patent No. 43056, Sep. 2007.
  3. “Stable Colloidal PEG Nanoparticles Fabricated by Electrospray Method”, Patent No. 43055, Sep. 2007.

 

 

Press enter to search
Press enter to search